We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Assertio Holdings Inc | NASDAQ:ASRT | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.05 | -4.50% | 1.06 | 1.03 | 1.06 | 1.11 | 1.00 | 1.07 | 1,124,433 | 00:32:13 |
From May 2022 to May 2024
For more information and to schedule an investor meeting, please contact Matt Kreps, investor relations for Assertio, at mkreps@darrowir.com. To arrange a business development meeting, please contact Vanessa Fox, Vice President, Business Development and Commercial Analytics for Assertio, at vfox@assertiotx.com.
About Assertio
Assertio is a specialty pharmaceutical company offering differentiated products to patients utilizing a non-personal promotional model. We have built and continue to build our commercial portfolio by identifying new opportunities within our existing products as well as acquisitions or licensing of additional approved products. To learn more visit www.assertiotx.com.
Investor Contact:
Matt KrepsManaging DirectorDarrow AssociatesM: 214-597-8200mkreps@darrowir.com
1 Year Assertio Chart |
1 Month Assertio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
